SBI Pharma Fund (Equity, Sectoral)

High
18 yrs 8 monthsStarted on:14 Jul 1999
₹ 1088.4 Cras on: 16 Feb 2018
Long Term Horizon
2.22%
Capital Appreciation

Minimum Investment

  • ₹ 5000.00 for Lumpsum

Investment Objective

The scheme seeks maximum growth opportunities through investments in Pharma stocks.

Exit Load

Scheme Documents

Similar Funds
Franklin Build India Fund
Return (CAGR) 18.31%
Crisil Ranking 3
Value Research
ICICI Prudential Banking And Financial Services Fund
Return (CAGR) 20.57%
Crisil Ranking NA
Value Research
SBI FMCG Fund
Return (CAGR) 16.11%
Crisil Ranking NA
Value Research NA
DSP BlackRock India T.I.G.E.R. Fund
Return (CAGR) 18.17%
Crisil Ranking 3
Value Research
RELIANCE BANKING FUND
Return (CAGR) 24.75%
Crisil Ranking NA
Value Research
HDFC Infrastructure Fund
Return (CAGR) 7.60%
Crisil Ranking 5
Value Research
UTI-Banking Sector Fund
Return (CAGR) 17.71%
Crisil Ranking NA
Value Research
Baroda Pioneer Banking And Financial Services Fund - Plan A
Return (CAGR) 13.50%
Crisil Ranking NA
Value Research
Birla Sun Life Banking And Financial Services Fund
Return (CAGR) 26.55%
Crisil Ranking NA
Value Research

Tenure

TenureReturns (CAGR)
3 Month0.90
3 YR0.71

SIP Returns

TenureReturns (CAGR)
5 YR6.92
10 YR16.85

Portfolio

Company Name% Assets
Divi's Laboratories Ltd.11.41
Cipla Ltd.9.79
Strides Shasun Ltd.7.71
Sun Pharmaceutical Inds. Ltd.6.39
Alkem Laboratories Ltd.6.06
Aurobindo Pharma Ltd.5.78
Torrent Pharmaceuticals Ltd.5.51
Cadila Healthcare Ltd.5.16
Natco Pharma Ltd.3.91
Gufic Biosciences Ltd.3.69

Top Sectoral Holdings

Sector Name% Assets
Healthcare96.43

Indicators

LabelValue
Portfolio turnover ratio66
Standard Deviation16.82%
Beta0.96%

Tanmaya Desai

Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).
Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.
© CRISIL Limited 2017. All Rights Reserved